Form 4 Filing for John G. Stratton

John G. Stratton, a director at ABBOTT LABORATORIES (ABT), acquired 397 Stock Equivalent Units on September 30, 2026. These units were credited to a grantor trust account and will be paid out generally at age 65 or upon retirement from the board. The units mirror the return of Abbott shares. Following this transaction, Stratton holds 14,499 Stock Equivalent Units, which includes units acquired through a dividend reinvestment feature. The transaction was reported on Form 4.